BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2021
View Archived Issues
Terns initiates dosing in first-in-human trial of TERN-501
Read More
Odonate Therapeutics discontinues development of tesetaxel
Read More
Encouraging preliminary phase I data for RP-L301 in pyruvate kinase deficiency
Read More
BioCryst presents successful data from proof-of-concept trial of BCX-9930 in PNH
Read More
FDA approves IND application for CBX-12
Read More
Avalon Globocare and MIT expand their codevelopment program
Read More
Evotec and Takeda enter multi-RNA target alliance
Read More
GRAd-COV2 vaccine candidate enters phase II/III development
Read More
CaaMTech patents new ammonium tryptamines for pain
Read More
Roche discloses HBeAg and HBsAg secretion inhibitors
Read More
Terns identifies thyroid hormone receptor beta agonists
Read More
Incyte synthesizes adenosine A2A and/or A2B receptor antagonists
Read More
Headless hemagglutinin makes for broad-spectrum flu vaccine
Read More
Updated results from ongoing phase I/II MATINS study of bexmarilimab
Read More
New anti-CD19 antibodies presented by Viela Bio
Read More
SOV-2012-F1, oral testosterone formulation that improves patient satisfaction scores
Read More
Tildacerfont: 12-week extension study data presented in patients with CAH
Read More
Genentech ends dosing in phase III study of tominersen for Huntington's disease
Read More
Akero reports phase IIa data on efruxifermin in patients with cirrhotic NASH
Read More
European grant supports consortium's development of mRNA for HPV16-positive cancers
Read More
FDA approves Zegalogue to treat severe hypoglycemia in children and adults with diabetes
Read More
CanSino reports China NMPA clearance of clinical trial application for inhaled COVID-19 vaccine
Read More
Regeneron reports topline phase III data on REGEN-COV in nonhospitalized COVID-19 patients
Read More
Japanese approval of Arikayce for NTM lung disease caused by MAC
Read More
Daiichi Sankyo's mRNA vaccine for COVID-19 enters phase I/II trial in Japan
Read More
Phase III VISION study of 177Lu-PSMA-617 meets primary endpoints in CRPC
Read More
Keytruda wins FDA approval for esophageal or GEJ carcinoma
Read More
Japanese MHLW approves Pemazyre for unresectable biliary tract cancer with FGFR2 fusion gene
Read More
Frequency Therapeutics reports phase IIa data on FX-322 in sensorineural hearing loss
Read More